Tehran University of Medical Sciences

Science Communicator Platform

Share By
Interdisciplinary Approach in Neurological Cancers Publisher



Sabahi M ; Hanaei S ; Rezaei N
Authors

Source: Interdisciplinary Cancer Research Published:2025


Abstract

Medical staffs who are in charge of treatment and care of patients with neurological cancers, such as neurosurgeons, neurologists, neuroradiologists, neurooncologists, neuropathologist, radiation oncologists, and medical oncologists, must have a thorough understanding of the neurologic manifestation and care of central nervous system (CNS) cancers in order to practice efficiently. Surgical intervention, radiation therapy (RT), and medicinal treatment with chemotherapy, immunotherapy, and/or targeted therapy are the cornerstones of treatment for most nervous system malignancies. In neuro-oncology, interdisciplinary collaboration is essential. Despite the implementation of novel medical therapy, the prognosis for many CNS cancers, such as gliomas and brain metastases, is generally dismal. Patients must be enrolled in clinical trials to evaluate the safety and efficiency of novel therapeutics paradigms. Tumor boards allow for continuous interaction and the creation of coordinated treatment strategies. Gliomas, meningiomas, primary CNS lymphoma, and CNS metastases are common CNS cancers that are treated with a mix of systemic therapeutic approaches, such as chemotherapy and targeted therapies, as well as surgery and RT. © The Author(s), under exclusive license to Springer Nature Switzerland AG 2022.
1. The Epidemiology of Brain and Spinal Cord Tumors, Advances in Experimental Medicine and Biology (2023)
2. Precision Medicine in Brain Tumors: New Approaches, Interdisciplinary Cancer Research (2025)
3. Grading Meningiomas by Used Imaging Features on Magnetic Resonance Imaging, Clinical Schizophrenia and Related Psychoses (2021)
Experts (# of related papers)
Other Related Docs
8. Tumor Immunology, Clinical Immunology (2022)
10. Spatial Profiling Technologies and Applications for Brain Cancers, Expert Review of Molecular Diagnostics (2021)
16. Exosomal Noncoding Rnas: Key Players in Glioblastoma Drug Resistance, Molecular and Cellular Biochemistry (2021)